tiqosi.wordpress.com
The company reported $92.4 milliom in revenue for the quarter endin gApril 30, up 2 percent from the same period last It earned $11 million in net income, or 33 centsa per diluted share, durinhg the second quarter, compareds with $9.2 million, or 28 centsw per diluted share, during the second quarter of last Analysts polled by expected the company to earn 29 centzs per share and $89 million in revenue. Martek (NASDAQ: MATK) sells nutritionalk oils derived from algaw that are used ininfant formula, dietary supplementsd and food products such as yogurtr and juice. Sales of its nutritional supplementx to the nursing market rose to arecord $9.
8 But the company warned that its infant formulaz sales in the third and fourtnh quarters could drop as retailerd trim their inventories of the The company anticipates that infanr formula revenue will grow in fiscal 2010 as a resul of strong demand for infant formula products containing its nutritional oils DHA and ARA. The Omega-3 fatty acids are believed to play an importanyt role in brain andeye development. study that couldx show that Martek’s DHA can slow the progressionhof Alzheimer’s disease.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment